Gupta Ashim, Sharif Kevin, Walters Megan, Woods Mia D, Potty Anish, Main Benjamin J, El-Amin Saadiq F
Department of Medical Microbiology, Immunology & Cell Biology, Southern Illinois University School of Medicine.
Division of Orthopaedics and Rehabilitation, Department of Surgery, Southern Illinois University School of Medicine.
J Vis Exp. 2014 Apr 30(86):51597. doi: 10.3791/51597.
Injury to the ACL is a commonly encountered problem in active individuals. Even partial tears of this intra-articular knee ligament lead to biomechanical deficiencies that impair function and stability. Current options for the treatment of partial ACL tears range from nonoperative, conservative management to multiple surgical options, such as: thermal modification, single-bundle repair, complete reconstruction, and reconstruction of the damaged portion of the native ligament. Few studies, if any, have demonstrated any single method for management to be consistently superior, and in many cases patients continue to demonstrate persistent instability and other comorbidities. The goal of this study is to identify a potential cell source for utilization in the development of a tissue engineered patch that could be implemented in the repair of a partially torn ACL. A novel protocol was developed for the expansion of cells derived from patients undergoing ACL reconstruction. To isolate the cells, minced hACL tissue obtained during ACL reconstruction was digested in a Collagenase solution. Expansion was performed using DMEM/F12 medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (P/S). The cells were then stored at -80 ºC or in liquid nitrogen in a freezing medium consisting of DMSO, FBS and the expansion medium. After thawing, the hACL derived cells were then seeded onto a tissue engineered scaffold, PLAGA (Poly lactic-co-glycolic acid) and control Tissue culture polystyrene (TCPS). After 7 days, SEM was performed to compare cellular adhesion to the PLAGA versus the control TCPS. Cellular morphology was evaluated using immunofluorescence staining. SEM (Scanning Electron Microscope) micrographs demonstrated that cells grew and adhered on both PLAGA and TCPS surfaces and were confluent over the entire surfaces by day 7. Immunofluorescence staining showed normal, non-stressed morphological patterns on both surfaces. This technique is promising for applications in ACL regeneration and reconstruction.
前交叉韧带损伤是活跃人群中常见的问题。即使是这条膝关节关节内韧带的部分撕裂也会导致生物力学缺陷,从而损害功能和稳定性。目前治疗部分前交叉韧带撕裂的方法包括非手术保守治疗以及多种手术选择,如:热改性、单束修复、完全重建以及对天然韧带受损部分进行重建。几乎没有研究(如果有的话)表明任何单一的治疗方法始终具有优越性,而且在许多情况下,患者仍表现出持续的不稳定和其他合并症。本研究的目的是确定一种潜在的细胞来源,用于开发一种组织工程补片,该补片可用于修复部分撕裂的前交叉韧带。我们开发了一种新的方案来扩增来自接受前交叉韧带重建患者的细胞。为了分离细胞,将在前交叉韧带重建过程中获得的切碎的人前交叉韧带组织在胶原酶溶液中消化。使用添加有10%胎牛血清(FBS)和1%青霉素/链霉素(P/S)的DMEM/F12培养基进行扩增。然后将细胞储存在-80℃或液氮中,冷冻培养基由二甲基亚砜、FBS和扩增培养基组成。解冻后,将源自人前交叉韧带的细胞接种到组织工程支架聚乳酸-乙醇酸共聚物(PLAGA)和对照组织培养聚苯乙烯(TCPS)上。7天后,进行扫描电子显微镜(SEM)检查以比较细胞在PLAGA和对照TCPS上的黏附情况。使用免疫荧光染色评估细胞形态。扫描电子显微镜照片显示,细胞在PLAGA和TCPS表面均生长并黏附,到第7天时在整个表面汇合。免疫荧光染色显示两个表面均呈现正常、无应激的形态模式。这项技术在应用于前交叉韧带再生和重建方面很有前景。